499 related articles for article (PubMed ID: 1386621)
1. Oral contraceptive use and cardiovascular disease: is the relationship real or due to study bias?
Katerndahl DA; Realini JP; Cohen PA
J Fam Pract; 1992 Aug; 35(2):147-57. PubMed ID: 1386621
[TBL] [Abstract][Full Text] [Related]
2. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
3. Results of oral contraceptive epidemiologic studies regarding neoplastic and cardiovascular effects.
Grimes DA
Int J Fertil; 1989; 34 Suppl():27-33. PubMed ID: 2576254
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptive risks: a realistic appraisal.
Bressler R; Durand JL
Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
Cole JA; Norman H; Doherty M; Walker AM
Obstet Gynecol; 2007 Feb; 109(2 Pt 1):339-46. PubMed ID: 17267834
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of oral contraceptives: a review.
Stubblefield PG
Int J Fertil; 1989; 34 Suppl():40-9. PubMed ID: 2576258
[TBL] [Abstract][Full Text] [Related]
7. [Vascular disease and hormonal treatment--epidemiology].
Vessey MP
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):121-6. PubMed ID: 12280197
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptive use and venous thromboembolism: a consideration of the impact of bias and confounding factors on epidemiological studies.
Rekers H; Norpoth T; Michaels MA
Eur J Contracept Reprod Health Care; 1996; 1(1):21-30. PubMed ID: 9678134
[TBL] [Abstract][Full Text] [Related]
9. Long-term health risks and benefits of oral contraceptive use.
Peterson HB; Lee NC
Obstet Gynecol Clin North Am; 1990 Dec; 17(4):775-88. PubMed ID: 2092241
[TBL] [Abstract][Full Text] [Related]
10. Risks of oral contraceptive use in women over 35.
Stenchever MA
J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptives and cardiovascular disease: a critique of the epidemiologic studies.
Realini JP; Goldzieher JW
Am J Obstet Gynecol; 1985 Jul; 152(6 Pt 2):729-98. PubMed ID: 3895946
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Contraception; 1998 May; 57(5):315-24. PubMed ID: 9673838
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptives. The current risk-benefit ratio.
Connell EB
J Reprod Med; 1984 Jul; 29(7 Suppl):513-23. PubMed ID: 6434735
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptive pills and the risk of venous thromboembolism.
Prog Hum Reprod Res; 1996; (39):2-3. PubMed ID: 12292198
[TBL] [Abstract][Full Text] [Related]
15. A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy.
Douketis JD; Ginsberg JS; Holbrook A; Crowther M; Duku EK; Burrows RF
Arch Intern Med; 1997 Jul; 157(14):1522-30. PubMed ID: 9236553
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptives and breast cancer. A meta-analysis.
Delgado-Rodriguez M; Sillero-Arenas M; Rodriguez-Contreras R; López Gigosos R; Gàlvez Vargas R
Rev Epidemiol Sante Publique; 1991; 39(2):165-81. PubMed ID: 1830968
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular disease and steroid hormone contraception. Report of a WHO Scientific Group.
World Health Organ Tech Rep Ser; 1998; 877():i-vii, 1-89. PubMed ID: 9615606
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of adverse cardiovascular outcomes associated with antecedent hypertension after myocardial infarction.
Chen G; Hemmelgarn B; Alhaider S; Quan H; Campbell N; Rabi D
Am J Cardiol; 2009 Jul; 104(1):141-7. PubMed ID: 19576336
[TBL] [Abstract][Full Text] [Related]
19. [Hormonal contraceptives and cardiovascular risk. Results of an East German multicenter case control study].
Meinel H; Göretzlehner G; Heinemann L
Zentralbl Gynakol; 1988; 110(23):1507-14. PubMed ID: 3071053
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials.
Kang S; Yang Y; Li CJ; Gao R
Clin Ther; 2007 Nov; 29(11):2406-18. PubMed ID: 18158081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
